Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery
Pharmaceutics · 23.09.2025 · 17 (10) · 1242
DOI: 10.3390/pharmaceutics17101242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 23.09.2025. Verfasst von Tobeka Naki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, Eastern Cape, South Africa. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Govan Mbeki Research and Development Council at the University of Fort Hare.
Abstract (Originalsprache)
Neurological-related diseases are among the most debilitating and difficult to manage. Many possible pharmacological treatments for neurological diseases struggle to cross the blood–brain barrier (BBB) to achieve concentrations that can produce a therapeutic benefit. This is primarily because of the existence of the BBB, which poses significant hurdles for both therapeutic and diagnostic efforts by restricting the entry of most medications. Nasal-to-brain drug transportation has surfaced as an encouraging approach to tackle the difficulties linked with conventional drug administration techniques for neurological disorders. In response, innovative methods for improving drug delivery focus on breaking down the BBB via physical techniques, including optical and photothermal therapy, electrical stimulation, and acoustic or mechanical stimulation. Nanocarriers represent a promising approach for facilitating nasal systemic and brain delivery of active compounds. Hence, the achievement of therapeutically relevant concentrations of exogenous molecules within the body is significantly contingent upon the nanocarriers’ capability to surpass biological barriers. Polymers in nanocarrier formulations can result in significantly enhanced nose-to-brain drug delivery by protecting drugs from premature biodegradation, increasing permeability, improving mucoadhesion, and targeting specific cells in the brain. Polymeric nanocarriers are frequently functionalized with cell-penetrating peptides to further improve the specificity of the loaded therapeutic molecules. This review focuses on the use of nanocarrier-based therapeutic agents to enhance the efficacy of nose-to-brain delivery systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, Eastern Cape, South Africa.
- Department of Chemistry, Nelson Mandela University, Gqeberha 6001, Eastern Cape, South Africa.
ORCID-Profile: Tobeka Naki, Sijongesonke Peter, Sibusiso Alven
Förderung
- Govan Mbeki Research and Development Council at the University of Fort Hare
Zitieren
APA
Naki, T., Peter, S., & Alven, S. (2025). Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery. Pharmaceutics, 17(10), 1242. https://doi.org/10.3390/pharmaceutics17101242
Vancouver
Naki T, Peter S, Alven S. Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery. Pharmaceutics. 2025;17(10):1242. doi:10.3390/pharmaceutics17101242
BibTeX
@article{Naki2025,
author = {Naki, Tobeka and Peter, Sijongesonke and Alven, Sibusiso},
title = {Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {10},
pages = {1242},
doi = {10.3390/pharmaceutics17101242}
}
EUVIMED